GlassScriptPhysician profile
April N Wazeka
NPI 1548234784
$1,448.92
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $382 · 2020: $187 · 2021: $427 · 2022: $453.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $212.91 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $203.46 | 2019-2022 | |
| Covis Pharma Gmbh | $202.59 | 2019-2022 | |
| Vertex Pharmaceuticals Incorporated | $123.31 | 2019-2022 | |
| Abbvie INC. | $94.36 | 2019-2021 | |
| Genzyme Corporation | $75.95 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $72.35 | 2019-2021 | |
| Alcresta Therapeutics, INC. | $59.81 | 2019 | |
| Glaxosmithkline, LLC. | $55.19 | 2019-2022 | |
| Mylan Specialty L.P. | $51.00 | 2019-2022 | |
| Biogen, INC. | $44.40 | 2020-2021 | |
| Chiesi USA, INC. | $39.15 | 2020-2022 | |
| Gilead Sciences, INC. | $32.04 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.43 | 2020-2021 | |
| Genentech USA, INC. | $28.80 | 2021-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $24.94 | 2022 | |
| Electromed, INC. | $19.08 | 2021 | |
| Insmed, INC. | $15.00 | 2019 | |
| Amgen INC. | $14.25 | 2022 | |
| Alk-Abello, INC | $13.66 | 2022 | |
| Vivus LLC | $13.64 | 2019 | |
| Allergan, INC. | $12.49 | 2019 | |
| Monaghan Medical Corporation | $11.11 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Wazeka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.